Loading...
GN Store Nord A/S
GNNDY•PNK
Healthcare
Medical - Devices
$48.40
$-1.08(-2.18%)
GN Store Nord A/S (GNNDY) Financial Performance & Income Statement Overview
Review GN Store Nord A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.75%
↓ 0.75%
Operating Income Growth
114.04%
↑ 114.04%
Net Income Growth
333.33%
↑ 333.33%
Operating Cash Flow Growth
3.30%
↑ 3.30%
Operating Margin
9.15%
↑ 9.15%
Gross Margin
53.15%
↑ 53.15%
Net Profit Margin
4.56%
↑ 4.56%
ROE
7.68%
↑ 7.68%
ROIC
7.33%
↑ 7.33%
GN Store Nord A/S (GNNDY) Income Statement & Financial Overview
Review GN Store Nord A/S's (GNNDY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.02B | $4.16B | $4.50B | $4.30B |
| Cost of Revenue | $2.35B | $1.88B | $2.25B | $2.12B |
| Gross Profit | $2.67B | $2.28B | $2.25B | $2.18B |
| Gross Profit Ratio | $0.53 | $0.55 | $0.50 | $0.51 |
| R&D Expenses | $355.00M | $343.00M | $442.00M | $351.00M |
| SG&A Expenses | -$1.91B | $1.39B | $1.52B | $1.38B |
| Operating Expenses | $2.07B | $1.77B | $2.05B | $1.73B |
| Total Costs & Expenses | $4.42B | $3.65B | $4.21B | $3.85B |
| Interest Income | $0.00 | $0.00 | $0.00 | $110.00M |
| Interest Expense | $0.00 | $0.00 | $140.00M | $110.00M |
| Depreciation & Amortization | $326.00M | $315.00M | $413.00M | $325.00M |
| EBITDA | $875.00M | $774.00M | $700.00M | $785.00M |
| EBITDA Ratio | $0.17 | $0.19 | $0.16 | $0.18 |
| Operating Income | $601.00M | $516.00M | $284.00M | $456.00M |
| Operating Income Ratio | $0.12 | $0.12 | $0.06 | $0.11 |
| Other Income/Expenses (Net) | -$98.00M | -$145.00M | -$140.00M | -$116.00M |
| Income Before Tax | $503.00M | $371.00M | $144.00M | $349.00M |
| Income Before Tax Ratio | $0.10 | $0.09 | $0.03 | $0.08 |
| Income Tax Expense | $111.00M | $82.00M | $32.00M | $77.00M |
| Net Income | $367.00M | $271.00M | $96.00M | $254.00M |
| Net Income Ratio | $0.07 | $0.07 | $0.02 | $0.06 |
| EPS | $2.52 | $1.86 | $0.66 | $1.74 |
| Diluted EPS | $2.52 | $1.86 | $0.66 | $1.74 |
| Weighted Avg Shares Outstanding | $145.61M | $145.61M | $145.61M | $145.61M |
| Weighted Avg Shares Outstanding (Diluted) | $145.71M | $145.68M | $145.61M | $145.66M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan